RAD51 and cancer: Thus, single-allele deletions of RAD51 and RAD51C appear to be haplo-insufficient in limiting APOBEC-induced mutation, which further supports a model in which HR factors are used to bypass APOBEC-induced abasic sites to reduce APOBEC-signature mutations in multiple human cancer types.